Travere Boosts Cash Position As Investors Brace For Filspari Data (NASDAQ:TVTX)
peakSTOCK/iStock via Getty Images Introduction Travere Therapeutics (NASDAQ:TVTX), a San Diego-based biopharmaceutical company, specializes in developing and delivering treatments for rare kidney, liver, and metabolic diseases. They recently received FDA accelerated approval for their lead product, sparsentan, targeting specific kidney disorders, and are also working on other treatments, including genetic disorders. Their efforts include expanding…